Skip to main content


Figure 2 | BMC Cancer

Figure 2

From: Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization

Figure 2

PharmGKB doxorubicin pharmacodynamic and pharmacokinetic pathways. Doxorubicin metabolic pathways were retrieved from the PharmGKB website (, combined, and used for further analysis. All diagrams are copyright PharmGKB. Used with permission from PharmGKB and Stanford University. (A) pharmacodynamics (B) Pharmacokinetics.

Back to article page